|
1
|
Yung YC, Stoddard NC, Mirendil H and Chun
J: Lysophosphatidic Acid signaling in the nervous system. Neuron.
85:669–682. 2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Choi JW, Herr DR, Noguchi K, Yung YC, Lee
CW, Mutoh T, Lin ME, Teo ST, Park KE, Mosley AN, et al: LPA
receptors: Subtypes and biological actions. Annu Rev Pharmacol
Toxicol. 50:157–186. 2010.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hecht JH, Weiner JA, Post SR and Chun J:
Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid
receptor expressed in neurogenic regions of the developing cerebral
cortex. J Cell Biol. 135:1071–1083. 1996.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ladrón de Guevara-Miranda D,
Moreno-Fernández RD, Gil-Rodríguez S, Rosell-Valle C,
Estivill-Torrús G, Serrano A, Pavón FJ, Rodríguez de Fonseca F,
Santín LJ and Castilla-Ortega E: Lysophosphatidic acid-induced
increase in adult hippocampal neurogenesis facilitates the
forgetting of cocaine-contextual memory. Addict Biol. 24:458–470.
2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lin C-I, Chen C-N, Lin P-W, Chang K-J,
Hsieh F-J and Lee H: Lysophosphatidic acid regulates
inflammation-related genes in human endothelial cells through LPA1
and LPA3. Biochem Biophys Res Commun. 363:1001–1008.
2007.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ren Y, Guo L, Tang X, Apparsundaram S,
Kitson C, Deguzman J, Fuentes ME, Coyle L, Majmudar R, Allard J, et
al: Comparing the differential effects of LPA on the barrier
function of human pulmonary endothelial cells. Microvasc Res.
85:59–67. 2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Baker DL, Desiderio DM, Miller DD, Tolley
B and Tigyi GJ: Direct quantitative analysis of lysophosphatidic
acid molecular species by stable isotope dilution electrospray
ionization liquid chromatography-mass spectrometry. Anal Biochem.
292:287–295. 2001.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Rivera-Lopez CM, Tucker AL and Lynch KR:
Lysophosphatidic acid (LPA) and angiogenesis. Angiogenesis.
11:301–310. 2008.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Rosenberg GA: Blood-brain barrier
permeability in aging and Alzheimer's disease. J Prev Alzheimers
Dis. 1:138–139. 2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
van de Haar HJ, Burgmans S, Jansen JF, van
Osch MJ, van Buchem MA, Muller M, Hofman PA, Verhey FR and Backes
WH: Blood-brain barrier leakage in patients with early Alzheimer
disease. Radiology. 281:527–535. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zenaro E, Piacentino G and Constantin G:
The blood-brain barrier in Alzheimer's disease. Neurobiol Dis.
107:41–56. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chakraborty A, de Wit NM, van der Flier WM
and de Vries HE: The blood brain barrier in Alzheimer's disease.
Vascul Pharmacol. 89:12–18. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Hwang SH, Shin TJ, Choi SH, Cho HJ, Lee
BH, Pyo MK, Lee JH, Kang J, Kim HJ, Park CW, et al: Gintonin, newly
identified compounds from ginseng, is novel lysophosphatidic
acids-protein complexes and activates G protein-coupled
lysophosphatidic acid receptors with high affinity. Mol Cells.
33:151–162. 2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Choi SH, Jung SW, Lee BH, Kim HJ, Hwang
SH, Kim HK and Nah SY: Ginseng pharmacology: A new paradigm based
on gintonin-lysophosphatidic acid receptor interactions. Front
Pharmacol. 6(245)2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Park H, Kim S, Rhee J, Kim HJ, Han JS, Nah
SY and Chung C: Synaptic enhancement induced by gintonin via
lysophosphatidic acid receptor activation in central synapses. J
Neurophysiol. 113:1493–1500. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kim S, Kim MS, Park K, Kim HJ, Jung SW,
Nah SY, Han JS and Chung C: Hippocampus-dependent cognitive
enhancement induced by systemic gintonin administration. J Ginseng
Res. 40:55–61. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Hwang SH, Shin EJ, Shin TJ, Lee BH, Choi
SH, Kang J, Kim HJ, Kwon SH, Jang CG, Lee JH, et al: Gintonin, a
ginseng-derived lysophosphatidic acid receptor ligand, attenuates
Alzheimer's disease-related neuropathies: Involvement of
non-amyloidogenic processing. J Alzheimers Dis. 31:207–223.
2012.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kim HJ, Shin EJ, Lee BH, Choi SH, Jung SW,
Cho IH, Hwang SH, Kim JY, Han JS, Chung C, et al: Oral
Administration of gintonin attenuates cholinergic impairments by
scopolamine, amyloid-β protein, and mouse model of Alzheimer's
disease. Mol Cells. 38:796–805. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Choi JH, Jang M, Nah SY, Oh S and Cho IH:
Multitarget effects of Korean Red Ginseng in animal model of
Parkinson's disease: Antiapoptosis, antioxidant, antiinflammation,
and maintenance of blood-brain barrier integrity. J Ginseng Res.
42:379–388. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Cho HJ, Choi SH, Kim HJ, Lee BH, Rhim H,
Kim HC, Hwang SH and Nah SY: Bioactive lipids in gintonin-enriched
fraction from ginseng. J Ginseng Res. 43:209–217. 2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Lee MJ, Jang M, Choi J, Chang BS, Kim DY,
Kim SH, Kwak YS, Oh S, Lee JH, Chang BJ, et al: Korean red ginseng
and ginsenoside-Rb1/-Rg1 alleviate experimental autoimmune
encephalomyelitis by suppressing Th1 and Th17 cells and
upregulating regulatory T cells. Mol Neurobiol. 53:1977–2002.
2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Saunders NR, Dziegielewska KM, Møllgård K
and Habgood MD: Markers for blood-brain barrier integrity: How
appropriate is Evans blue in the twenty-first century and what are
the alternatives? Front Neurosci. 9(385)2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Flynn KM, Michaud M, Canosa S and Madri
JA: CD44 regulates vascular endothelial barrier integrity via a
PECAM-1 dependent mechanism. Angiogenesis. 16:689–705.
2013.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Kalinowska A and Losy J: PECAM-1, a key
player in neuroinflammation. Eur J Neurol. 13:1284–1290.
2006.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Al-Obaidi MM and Desa MN: Mechanisms of
blood brain barrier disruption by different types of bacteria, and
bacterial-host interactions facilitate the bacterial pathogen
invading the brain. Cell Mol Neurobiol. 38:1349–1368.
2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Almutairi MM, Gong C, Xu YG, Chang Y and
Shi H: Factors controlling permeability of the blood-brain barrier.
Cell Mol Life Sci. 73:57–77. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wallez Y and Huber P: Endothelial adherens
and tight junctions in vascular homeostasis, inflammation and
angiogenesis. Biochim Biophys Acta. 1778:794–809. 2008.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Marco S and Skaper SD: Amyloid
beta-peptide1-42 alters tight junction protein distribution and
expression in brain microvessel endothelial cells. Neurosci Lett.
401:219–224. 2006.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Liu Z, Liu J, Wang S, Liu S and Zhao Y:
Neuronal uptake of serum albumin is associated with neuron damage
during the development of epilepsy. Exp Ther Med. 12:695–701.
2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wolburg H, Wolburg-Buchholz K, Kraus J,
Rascher-Eggstein G, Liebner S, Hamm S, Duffner F, Grote EH, Risau W
and Engelhardt B: Localization of claudin-3 in tight junctions of
the blood-brain barrier is selectively lost during experimental
autoimmune encephalomyelitis and human glioblastoma multiforme.
Acta Neuropathol. 105:586–592. 2003.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Hwang SH, Lee BH, Choi SH, Kim HJ, Won KJ,
Lee HM, Rhim H, Kim H-C and Nah SY: Effects of gintonin on the
proliferation, migration, and tube formation of human
umbilical-vein endothelial cells: Involvement of
lysophosphatidic-acid receptors and
vascular-endothelial-growth-factor signaling. J Ginseng Res.
40:325–333. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Choi SH, Kim HJ, Cho HJ, Park SD, Lee NE,
Hwang SH, Rhim H, Kim HC, Cho IH and Nah SY: Gintonin-mediated
release of astrocytic vascular endothelial growth factor protects
cortical astrocytes from hypoxia-induced cell damages. J Ginseng
Res. 43:305–311. 2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Religa P, Cao R, Religa D, Xue Y,
Bogdanovic N, Westaway D, Marti HH, Winblad B and Cao Y: VEGF
significantly restores impaired memory behavior in Alzheimer's mice
by improvement of vascular survival. Sci Rep.
3(2053)2013.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Shen F, Walker EJ, Jiang L, Degos V, Li J,
Sun B, Heriyanto F, Young WL and Su H: Coexpression of
angiopoietin-1 with VEGF increases the structural integrity of the
blood-brain barrier and reduces atrophy volume. J Cereb Blood Flow
Metab. 31:2343–2351. 2011.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Balducci C and Forloni G: Novel targets in
Alzheimer's disease: A special focus on microglia. Pharmacol Res.
130:402–413. 2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Cai Z, Zhao B and Ratka A: Oxidative
stress and β-amyloid protein in Alzheimer's disease. Neuromolecular
Med. 13:223–250. 2011.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Saba E, Jeon BR, Jeong DH, Lee K, Goo YK,
Kwak D, Kim S, Roh SS, Kim SD, Nah SY, et al: A novel Korean red
ginseng compound gintonin inhibited inflammation by MAPK and NF-κB
pathways and recovered the levels of mir-34a and mir-93 in RAW
264.7 cells. Evid Based Complement Alternat Med.
2015(624132)2015.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Jo MG, Ikram M, Jo MH, Yoo L, Chung KC,
Nah SY, Hwang H, Rhim H and Kim MO: Gintonin mitigates MPTP-induced
loss of nigrostriatal dopaminergic neurons and accumulation of
α-synuclein via the Nrf2/HO-1 pathway. Mol Neurobiol. 56:39–55.
2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Kim HJ, Kim DJ, Shin EJ, Lee BH, Choi SH,
Hwang SH, Rhim H, Cho IH, Kim HC and Nah SY: Effects of
gintonin-enriched fraction on hippocampal cell proliferation in
wild-type mice and an APPswe/PSEN-1 double Tg mouse model of
Alzheimer's disease. Neurochem Int. 101:56–65. 2016.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Choi JH, Jang M, Oh S, Nah SY and Cho IH:
Multi-target protective effects of gintonin in
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-mediated model of
Parkinson's disease via lysophosphatidic acid receptors. Front
Pharmacol. 9(515)2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Jang M, Choi JH, Chang Y, Lee SJ and Nah
SY and IH: Gintonin, a ginseng-derived ingredient, as a novel
therapeutic strategy for Huntington's disease: Activation of the
Nrf2 pathway through lysophosphatidic acid receptors. Brain Behav
Immun. 80:146–162. 2019.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Kim DG, Jang M, Choi SH, Kim HJ, Jhun H,
Kim HC, Rhim H, Cho IH and Nah SY: Gintonin, a ginseng-derived
exogenous lysophosphatidic acid receptor ligand, enhances
blood-brain barrier permeability and brain delivery. Int J Biol
Macromol. 114:1325–1337. 2018.PubMed/NCBI View Article : Google Scholar
|
